GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is ...

Excluding the impact of foreign exchange, sales increased 9%. Merck reported adjusted ... Merck reported a decline of 17% in sales of Gardasil to $1.55 billion, a vaccine that prevents cancer ...

The increase is driven by growth in oncology and cardiovascular, partially offset by declines in diabetes, vaccines ... to temporarily pause Gardasil/Gardasil 9 shipments into China beginning ...

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

(Reuters) -Merck said on Tuesday it would not ship its HPV vaccine ... earn $8.88 to $9.03 per share this year, compared with analysts estimates of $9.03 a share. Quarterly Gardasil sales of ...

Excluding the impact of foreign exchange, sales increased 9%. Merck reported adjusted EPS of $1. ... Merck reported a decline of 17% in sales of Gardasil to $1.55 billion, a vaccine that prevents ...

Merck reported a 2% decline in Gardasil sales, after reaching a peak of $8.9 billion in 2023. Now with shipments to China paused, the HPV vaccine faces significant headwinds going into 2025.

The company said that sales range reflects a decision to halt shipments of Gardasil ... vaccines and medicines for dogs, cats and cattle, posted nearly $1.4 billion in sales, up 9% from the ...